Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

MLA

Kim, Chan, et al. “Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.” Cancer Cell, vol. 25, no. 1, Jan. 2014, pp. 102–17. EBSCOhost, https://doi.org/10.1016/j.ccr.2013.12.010.

APA

Kim, C., Yang, H., Fukushima, Y., Saw, P., Lee, J., Park, J.-S., Park, I., Jung, J., Kataoka, H., Lee, D., Do, H. W., Kim, I., Jon, S., Adams, R. H., Nishikawa, S.-I., Uemura, A., & Koh, G. (2014). Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption. Cancer Cell, 25(1), 102–117. https://doi.org/10.1016/j.ccr.2013.12.010

Chicago

Kim, Chan, Hanseul Yang, Yoko Fukushima, Phei?Er Saw, Junyeop Lee, Jin-Sung Park, Intae Park, et al. 2014. “Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.” Cancer Cell 25 (1): 102–17. doi:10.1016/j.ccr.2013.12.010.